XDH and hyperuricemia: Xanthine oxidase (XOD) catalyzes the oxidation of hypoxanthine or xanthine to uric acid in the liver (Chen et al., 2016; Qin et al., 2018), which is considered to be a promising therapeutic target for hyperuricemia caused by overproduction of uric acid (Richette and Bardin, 2010).